Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain.
Open Access
- 31 March 1984
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 259 (7), 4672-4680
- https://doi.org/10.1016/s0021-9258(17)43099-7
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Mass spectrometry of a human tumor glycolipid antigen being defined by mouse monoclonal antibody NS-19-9Biochemical and Biophysical Research Communications, 1983
- The common structure in fucosyllactosaminolipids accumulating in human adenocarcinomas, and its possible absence in normal tissueBiochemical and Biophysical Research Communications, 1982
- Complete analysis of oligosaccharide primary structure using two-dimensional high-field proton NMRJournal of the American Chemical Society, 1982
- GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.The Journal of Experimental Medicine, 1982
- The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: A preliminary noteBiochemical and Biophysical Research Communications, 1981
- Therapy of Mouse Lymphoma with Monoclonal Antibodies to Glycolipid: Selection of Low Antigenic Variants in VivoScience, 1981
- Use of mass spectrometry for the carbohydrate composition and sequence analysis of glycosphingolipidsJournal of Mass Spectrometry, 1974
- Cellular blood group substances. III. Isolation and characterization of glycosphingolipids with blood group H specificity from membranes of human erythrocytesBiochemistry, 1973
- Sphingoglycolipids with Leb activity, and the co-presence of Lea-, Leb-glycolipids in human tumor tissueBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970
- Isolation of Gangliosides.Acta Chemica Scandinavica, 1963